# PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc

> **NCT04814095** · NA · RECRUITING · sponsor: **British Columbia Cancer Agency** · enrollment: 30 (estimated)

## Conditions studied

- Cancer

## Interventions

- **BEHAVIORAL:** QOL
- **DIAGNOSTIC_TEST:** CT imaging

## Key facts

- **NCT ID:** NCT04814095
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-30
- **Primary completion:** 2028-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814095, "PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04814095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*